InvestSMART

Radiopharm Theranostics Limited (ASX:RAD)

ALERT: Price-sensitive ASX Announcement for RAD
Current share price for RAD : $0.010 -0.009 (-47.37%)+
Announcement
Release
24 Jul 2026 5:20PM
Price at Release
$0.019
Full Release
download
Summary
Radiopharm Theranostics Limited announced the successful completion of a A$12.5 million capital raising, through both an Australian and US placement. The Australian Placement involved two tranches totaling approximately A$6.7 million, while the US placement generated approximately US$4.1 million. Following this, a Share Purchase Plan (SPP) will raise up to A$6 million, offering existing shareholders the chance to invest without brokerage fees. Each new share from the Australian Placement and SPP comes with an attaching option, exercisable at A$0.018, expiring in July 2029. The capital raised will fund upcoming clinical studies and strategic initiatives.
Key Points
  • Completion of A$12.5 million institutional capital raising.
  • A$6.7 million raised through Australian Placement.
  • US Direct Registration Offering raised approximately US$4.1 million.
  • Launch of A$6 million Share Purchase Plan (SPP) for existing shareholders.
  • Attaching Options offered with each new share, exercisable at A$0.018.
  • Funds to support clinical studies and strategic initiatives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.